Nomi Tablet

About Nomi 2.5 mg Tablet

Nomi 2.5 mg Tablet is a migraine treatment that contains the active ingredient zolmitriptan. It is used to relieve an attack of migraine headache in adults, with or without aura.

There are 4 brands of Zolmitriptan listed in Bangladesh. 3 of them have a lower unit price than Nomi. The lowest listed price is Zomitan 2.5 mg Tablet at ৳ 10.00 per unit.

What is Nomi 2.5 mg Tablet?

Nomi 2.5 mg Tablet is an acute migraine medicine containing zolmitriptan, which belongs to a group of medicines called 5-HT agonists. It works on blood vessels and sensory nerves in the head to help relieve a migraine attack that has already started. It is intended for adults and is not a preventive medicine, so it is not taken to stop migraines from happening. The tablet comes in a 2.5 mg strength and is supplied by Square Pharmaceuticals PLC. It is used for migraine with or without aura. Your doctor will explain whether it is suitable for your headaches and how it should fit into your treatment.

Uses of Nomi

Nomi 2.5 mg Tablet is used for the acute treatment of migraine attacks, both with and without aura, in adults. This means it is taken when a migraine has already begun, to help relieve the headache and associated symptoms of that attack. It is not used to prevent future migraines. If your headaches are frequent or you are unsure whether your symptoms are migraine, your doctor can assess you and decide on the right treatment. The dose and course are set by your doctor.

How to use Nomi

Take Nomi 2.5 mg Tablet as your doctor directs. The doctor decides the dose, whether a second dose is needed and the course of treatment. Swallow the tablet with water unless your doctor advises otherwise. Do not take more than your doctor has told you to. If your migraine does not improve or returns, speak to your doctor or pharmacist before taking more. Store the medicine below 30°C, protected from light and moisture, and keep it out of the reach of children.

Side effects of Nomi

Some people notice side effects after taking Nomi 2.5 mg Tablet. Commonly reported reactions include neck, throat or jaw pain or pressure, dizziness, tingling sensations, weakness, drowsiness, warm or cold sensations, nausea, a feeling of heaviness and dry mouth. Tightness, pain or pressure in the chest, throat, neck or jaw can also occur. Tell your doctor if these are troublesome or do not settle. Serious heart reactions have rarely been reported, so get urgent medical help for severe chest pain or other worrying symptoms.

Safety and precautions

Nomi 2.5 mg Tablet is not suitable for everyone. It should not be used by people with ischaemic coronary artery disease, a history of stroke, or a known allergy to zolmitriptan, or by those taking a monoamine oxidase inhibitor or who have taken one recently. Tell your doctor about heart problems, other medicines and your full medical history. Pregnancy is classified as Category C, so it should be used only if the benefit justifies the potential risk to the fetus. It is not known whether zolmitriptan passes into human milk, so your doctor will decide whether to stop nursing or stop the medicine.

Frequently asked questions

What is the price of Nomi 2.5 mg Tablet?

The listed price is ৳ 25.17. Ask your pharmacist about availability and any other costs before you buy.

Who should avoid Nomi 2.5 mg Tablet or ask the doctor first?

Do not take it if you have ischaemic coronary artery disease, a history of stroke, an allergy to zolmitriptan, or if you take or have recently taken a monoamine oxidase inhibitor. Tell your doctor about any heart problems or other medicines before using it.

What side effects should I watch for, and when should I call the doctor?

Watch for neck, throat or jaw pressure, dizziness, drowsiness, nausea, dry mouth and chest tightness. Contact your doctor if these are severe or persistent. Get urgent help for severe chest pain or other serious symptoms.

Is Nomi 2.5 mg Tablet safe in pregnancy or breastfeeding?

It is in Pregnancy Category C and should be used in pregnancy only if the benefit justifies the potential risk to the fetus. It is not known whether it passes into human milk, so your doctor will decide whether to stop nursing or stop the medicine.

Indications

Zolmitriptan is indicated for the acute treatment of migraines with or without aura in adults.

Pharmacology

Migraines are likely due to local cranial vasodilatation and/or to the release of sensory neuropeptides through nerve endings in the trigeminal system. The therapeutic activity of Zolmitriptan for the treatment of migraine headache is thought to be due to the agonist effects at the 5-HT1B/1D receptors on intracranial blood vessels and sensory nerves of the trigeminal system which results in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release.

Dosage & Administration

Tablet: The recommended starting dose of Zolmitriptan is 2.5 mg tablet. Maximum recommended single dose is 5 mg. If the migraine has not resolved by 2 hours after taking Zolmitriptan, or returns after a transient improvement, a second dose may be administered at least 2 hours after the first dose. The maximum daily dose is 10 mg in any 24-hours period.

Nasal Spray: Administer one dose of Zolmitriptan Nasal Spray 5 mg for the treatment of acute migraine. If the headache returns the dose may be repeated after 2 hours. The maximum daily dose should not exceed 10 mg in any 24-hour period. In controlled clinical trials, single doses of 5 mg zolmitriptan nasal spray were administered into one nostril and were effective for the treatment of acute migraines in adults. Individuals may vary in response to Zolmitriptan Nasal Spray. The pharmacokinetics of a 5 mg nasal spray dose is similar to the 5 mg oral formulations. Doses lower than 5 mg can only be achieved through the use of an oral formulation. The choice of dose, and route of administration should therefore be made on an individual basis. The effectiveness of a second dose has not been established in placebo-controlled trials. The safety of treating an average of more than four headaches in a 30 day period has not been established.

Contraindications

Contraindicated in patients with ischemic coronary artery disease, history of stroke, concurrent or recent use of a monoamine oxidase inhibitor and known hypersensitivity to Zolmitriptan.

Side Effects

Most common adverse reactions were neck/throat/jaw pain or pressure, dizziness, paresthesia, asthenia, somnolence, warm/cold sensation, nausea, heaviness sensation, and dry mouth.

Pregnancy & Lactation

Pregnancy Category C. Zolmitriptan should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Zolmitriptan is excreted in human milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration. Sensations of tightness, pain, and pressure may occur in the chest, throat, neck, and jaw after treatment with Zolmitriptan.

Storage Conditions

Protect from light and moisture, store below 30°C. Keep the medicine out of the reach of children.

Alternative brands of Zolmitriptan

Other brands with the same generic name, cheapest first.

Zomitan Tablet

2.5 mg

Zolmitriptan

Incepta Pharmaceuticals Ltd.

৳ 9.8 ৳ 10.00 2% off per unit

Zomitan Tablet

5 mg

Zolmitriptan

Incepta Pharmaceuticals Ltd.

৳ 9.8 ৳ 10.00 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.